This article was originally written for Genome Alberta’s Genomics Blog.
If I asked you to think about words you associate with “Alberta,” I bet many of you would probably not have picked “virology.” But Alberta is home to some cutting-edge research in virology that could pave the way to all sorts of new therapies in the future.
The University of Alberta is home to the Li Ka Shing Applied Virology Institute (LKSAVI). The Institute supports early-stage life science research with funding and commercialization guidance.
“The services we render are customized to each research project,” says Ana Clementin, Operations Manager at the LKSAVI. “We want to move them from a pre-startup phase and prepare them to meet with industry partners and investors.”
So what exactly is the LKSAVI doing right now?